Marek Honczarenko

Title: Innovations by Marek Honczarenko

Introduction

Marek Honczarenko is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. With a total of 4 patents to his name, Honczarenko's work has the potential to impact many lives.

Latest Patents

Honczarenko's latest patents include innovative methods for treating systemic lupus erythematosus and other autoimmune diseases. One of his patents focuses on methods of treating systemic lupus erythematosus using a domain antibody directed against CD28. This method involves at least one administration cycle comprising one dose of the domain antibody, which has been shown to reduce symptoms compared to placebo. Another significant patent addresses methods of treating autoimmune diseases using a domain antibody directed against CD40L. This method provides treatments for conditions such as primary immune thrombocytopenia, solid organ transplant rejection, and more. The antibody polypeptides used in this method do not activate platelets and can be administered intravenously at doses ranging from about 75 mg to about 1500 mg, normalizing platelet counts in patients.

Career Highlights

Marek Honczarenko is currently associated with Bristol-Myers Squibb Company, where he continues to advance his research and innovations. His work is characterized by a commitment to developing effective treatments for complex autoimmune conditions.

Collaborations

Honczarenko collaborates with esteemed colleagues, including Suzanne J. Suchard and Xiaoni Liu, to further enhance the impact of his research and innovations.

Conclusion

Marek Honczarenko's contributions to the field of medicine through his patents and collaborations highlight his dedication to improving treatment options for autoimmune diseases. His work exemplifies the importance of innovation in healthcare.